All News


 

2016

June

Media Release / Jun 07, 2016

Sandoz Canada is committed to maintain a supply of injectable medicines during work stoppage by unionized employees at its Boucherville facility

Read More

May

Media Release / May 31, 2016

Sandoz broadens its pharmaceutical portfolio with EURO-PHARM's North American product line

Read More
Media Release / May 17, 2016

Sandoz Canada launches PrSandoz® Duloxetine, a generic version of Cymbalta*, for the treatment of depression and anxiety symptoms

Read More

March

Media Release / Mar 31, 2016

Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI* indicated for pulmonary infections in cystic fibrosis patients

Read More
Media Release / Mar 02, 2016

Sandoz Canada expands its cancer medication portfolio with the launch of PrOxaliplatin Injection

Read More

February

Media Release / Feb 16, 2016

Corporate Responsibility

Read More
Media Release / Feb 12, 2016

Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer’s biosimilar infliximab in EEA

Read More
Media Release / Feb 11, 2016

Sandoz advances its biosimilars program with EMA acceptance of regulatory submission for biosimilar pegfilgrastim

Read More

January

Media Release / Jan 04, 2016

New Research highlights need for a competitive functioning biologics market to achieve full potential of Biosimilars

Read More
2015

November

Media Release / Nov 18, 2015

Regulatory submission for Sandoz’ proposed biosimilar pegfilgrastim accepted by the FDA

Read More